News Archive
10/16/07 Acucela Paper Published in Experimental Eye Research
10/09/07 Award of Phase I SBIR Grant from NIH
08/21/07 Acucela Announces Screening Collaboration To Identify Novel Drugs For Macular Degeneration
06/11/07 Acucela Awarded NIH/SBIR Grant for Environmental Retinal Toxicology Program
04/05/07 Biotech Company Acucela Inc. Secures $25M in Additional Financing
01/27/07 Acucela Paper Published in Investigative Ophthalmology and Visual Science
09/06/06 Acucela to Participate at BioJapan World Business Forum
07/14/06 Acucela Paper Published in Investigative Ophthalmology and Visual Science
07/12/06 Acucela Presents at ARVO Summer Conference on Macular Degeneration
11/24/04 Acucela Inc. Secures $13.4 M in Series B Financing
11/22/04 Acucela Leading Ophthalmology Researcher to Join Acucela's Scientific Advisory Board
08/04/04 Pharmaceutical Executive to Join Acucela's Scientific Advisory Board
06/20/04 Olympus and Acucela Inc. Extend Collaboration
04/26/04 Toyama Chemical Co., Ltd., and Acucela Inc. Enter into Collaboration for Potential Ophthalmic Treatments
09/04/03 UW Signs Licensing Agreement for Study of Eye Disease
09/04/03 Asahi News: "Former Assistant Professor of the University of Washington Starts Pharmaceutical Venture Company"
07/25/03 Olympus Optical and Acucela Inc. Form Collaboration
06/25/03 Nikkei Sangyo News: "Long Term Culture of Neuronal Cells Used in Efficacy Testing for New Drugs"